GeminIQ Website Logo

Viewing AVNS free

Subscribe for full history, 50+ metrics, screener, watchlist...

AVANOS MEDICAL, INC.

AVNS

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

AVANOS MEDICAL, INC. (AVNS) — SEC Financial Statements & Analysis

AVANOS MEDICAL, INC. (AVNS) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
66907190971088992768810782
Accounts Receivable Net
103104112110105133132123131143145152
Assets Current
Assets Current
325355351356352393473474468487525507
Inventory Net
141148151143138139162164166163157148
Prepaid Expense And Other Assets Current
151419131314162229291416
Assets Of Disposal Group Including Discontinued Op…
-----074736765102109
Property Plant And Equipment Net
111113115114110111110111116117117123
Operating Lease Right Of Use Asset
392830313234272924272729
Goodwill
394395394381456456795794795796792763
Intangible Assets Net Excluding Goodwill
115118122105107112220226233240242223
Deferred Income Tax Assets Net
333325252525766744
Other Assets Noncurrent
333229262523261719191819
Disposal Group Including Discontinued Operation As…
----------00
Assets
1,0501,0741,0681,0391,1081,1541,6561,6581,6611,6921,7251,667
Liabilities And Stockhold…
Long Term Debt Current
111099999109966
Operating Lease Liability Current
10810101011141412131314
Liabilities Current
Liabilities Current
131165148135137166213208205235171161
Accounts Payable Current
525654494654545157565265
Accrued Liabilities Current
589175667191838075939773
Liabilities Of Disposal Group Including Discontinu…
-----05353526433
Long Term Debt
8790939698125153165167159258203
Operating Lease Liability Noncurrent
302021222325272927283031
Deferred Income Tax Liabilities Net
666666242324242922
Other Liabilities Noncurrent
141421454111111101615
Liabilities Of Disposal Group Including Discontinu…
----------00
Liabilities
268296290263268326427436433456503432
Stockholders Equity Inclu…
Preferred Stock Value
000000000000
Common Stock Value
111111111111
Additional Paid In Capital
1,6961,6921,6911,6871,6831,6791,6751,6721,6681,6641,6601,655
Stockholders Equity
Stockholders Equity
7827787787768398291,2301,2221,2281,2361,2221,235
Retained Earnings Accumulated Deficit
-775-780-779-777-700-707-310-314-316-315-325-322
Treasury Stock Common Value
-104-102-102-102-101-99-99-99-95-86-80-71
Accumulated Other Comprehensive Income Loss Net Of…
-36-32-33-32-42-45-37-38-30-27-33-28
Liabilities And Stockholders Equity
1,0501,0741,0681,0391,1081,1541,6561,6581,6611,6921,7251,667
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
202020202020202020202020
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
300300300300300300300300300300300300
Shares Outstanding
474646464646464646464647

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.40%1.01%----------
2025-2.18%-4.98%-6.54%20.73%19.01%19.21%10.13%7.04%22.80%-4.33%80.50%81.16%
20241.27%-0.76%11.57%-1.21%0.92%-2.51%0.11%-13.46%-14.32%-6.08%-20.42%-16.07%
2023----8.46%-13.63%-23.92%2.07%9.67%-9.14%-2.15%-5.13%0.36%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.48
2.15
2.38
2.64
2.57
2.37
2.22
2.28
2.28
2.08
3.07
3.16
Quick Ratio
1.29
1.17
1.23
1.49
1.47
1.45
1.38
1.38
1.33
1.26
2.08
2.14
Working Capital
193.80M
190.20M
203.50M
221.40M
215.20M
227.50M
259.70M
265.90M
262.60M
252.40M
353.90M
346.40M
Leverage & Debt
Debt to Equity
0.34
0.38
0.37
0.34
0.32
0.39
0.35
0.36
0.35
0.37
0.41
0.35
Interest Coverage TTM
-
-
-
-
-
-127.81
5.23
2.05
0.98
0.28
-0.20
0.66
Debt Ratio
0.26
0.28
0.27
0.25
0.24
0.28
0.26
0.26
0.26
0.27
0.29
0.26
Efficiency & Turnover
Asset Turnover TTM
0.66
0.63
0.51
0.51
0.50
0.48
0.40
0.41
0.40
0.39
0.37
0.38
Per Share Metrics
Diluted EPS TTM
-1.57
-1.57
-10.11
-10.00
-8.22
-8.52
0.34
0.17
-1.33
-1.33
-1.18
-0.77
Free Cash Flow Per Share TTM
0.16
0.93
1.61
1.90
2.47
1.80
0.80
0.91
0.29
0.31
0.78
0.74
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
50.05%
50.47%
52.28%
53.83%
54.60%
55.44%
55.51%
55.82%
56.33%
56.39%
57.58%
58.22%
Operating Profit Margin TTM
-8.80%
-8.78%
-68.95%
-67.97%
-56.57%
-57.60%
4.92%
3.33%
2.10%
0.62%
-0.47%
1.33%
Net Profit Margin TTM
-10.39%
-10.40%
-67.00%
-66.89%
-55.80%
-57.01%
2.30%
1.13%
-9.15%
-9.18%
-8.61%
-5.59%
Growth Metrics
Net Revenue Growth (1Y)
3.87%
1.95%
2.70%
1.48%
1.34%
2.15%
5.91%
5.88%
5.28%
-1.58%
-12.33%
-13.58%
Net Income Growth (1Y)
-80.66%
-81.41%
-3,086.62%
-6,115.58%
518.33%
534.47%
-128.34%
-121.39%
-239.46%
-222.38%
-223.39%
490.16%
EPS Growth (1Y)
-80.82%
-81.53%
-3,060.88%
-6,063.61%
519.67%
542.74%
-128.83%
-121.81%
-240.67%
-223.16%
-222.86%
495.21%
Valuation Metrics
P/E TTM
-8.76
-7.13
-1.14
-1.22
-1.72
-1.87
70.41
118.74
-14.79
-16.91
-17.08
-33.23
P/B
0.83
0.67
0.69
0.73
0.79
0.88
0.90
0.75
0.75
0.85
0.77
0.97
P/S TTM
0.91
0.74
0.77
0.82
0.96
1.06
1.62
1.34
1.35
1.55
1.47
1.86
Market Cap
651.47M
519.95M
536.38M
566.71M
660.61M
732.32M
1.11B
914.33M
919.84M
1.05B
946.30M
1.20B
Enterprise Value
673.17M
520.45M
559.28M
572.11M
661.61M
749.92M
1.17B
987.03M
1.01B
1.12B
1.10B
1.32B
Calculated Values
Free Cash Flow TTM
7.50M
43.10M
74.90M
87.90M
114.00M
82.90M
36.60M
41.80M
13.30M
14.60M
36.60M
34.50M
Net Debt
21.70M
500.00K
22.90M
5.40M
1.00M
17.60M
63.60M
72.70M
91.40M
71.70M
151.20M
121.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-18Sale
Owner: Holbrook, Kerr
Title: SVP, Chief Commercial Officer
Shares: 15,000
Price/Share: $11.01
Value: $165,150.00
Shares Owned: 83,860
Relationship: Officer
Ownership: Direct
2025-08-13Purchase
Owner: Blackford, Gary
Title: -
Shares: 20,000
Price/Share: $10.98
Value: $219,600.00
Shares Owned: 91,593
Relationship: Director
Ownership: Direct
2025-03-06Sale
Owner: Holbrook, Kerr
Title: SVP, Chief Commercial Officer
Shares: 7,000
Price/Share: $15.25
Value: $106,750.00
Shares Owned: 82,047
Relationship: Officer
Ownership: Direct
2024-03-14Sale
Owner: Greiner, Michael
Title: SVP - Chief Financial Officer
Shares: 8,000
Price/Share: $19.14
Value: $153,120.00
Shares Owned: 151,495
Relationship: Officer
Ownership: Direct
2024-03-11Purchase
Owner: Shimer, Julie Ann
Title: -
Shares: 500
Price/Share: $19.85
Value: $9,925.00
Shares Owned: 50,090
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
78.58%
Inst. Shares: 36,540,139
Shares Outstanding: 46,500,000
2025-12-31
115.94%
Inst. Shares: 53,679,204
Shares Outstanding: 46,300,000
2025-09-30
83.39%
Inst. Shares: 38,694,402
Shares Outstanding: 46,400,000
2025-06-30
82.16%
Inst. Shares: 38,040,066
Shares Outstanding: 46,300,000
2025-03-31
84.24%
Inst. Shares: 38,835,446
Shares Outstanding: 46,100,000

Research Faster.
Invest Smarter.

AVANOS MEDICAL, INC. (AVNS) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.